CMRA - Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc.

12 Gill Street
Suite 4650
Woburn, MA 01801
United States
617-871-2101
https://comeralifesciences.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 12

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jeffrey S. Hackman	Chairman, Pres & CEO	400k	N/A	1961
Mr. Michael G. Campbell CPA	Exec. VP & CFO	269.11k	N/A	1969
Dr. Neal I. Muni M.D., MSPH	Exec. VP & COO	350k	N/A	1975
Dr. David Soane Ph.D.	Co-Founder & Member of Scientific Advisory Board	N/A	N/A	N/A
Dr. Robert P. Mahoney Ph.D.	Chief Scientific Officer	N/A	N/A	1964
Ms. Janice Marie McCourt B.S., CLP, M.B.A., R.Ph.	Chief Bus. Officer	N/A	N/A	1962

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

Corporate governance

Comera Life Sciences Holdings, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.